Androgen Suppression Strategies for Prostate Cancer: Is There an Ideal Approach?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11934-011-0178-0.pdf
Reference50 articles.
1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.
2. Collette L, Struder U, Iversen P, et al. Is the degree of PSA decline after immediate androgen deprivation a prognostic factor for outcome in patients with T0-4, N0, M0 prostate cancer not suitable for local treatment with curative intent? Paper presented at: 21st Congress of the European Association of Urology; April 5–8, Paris, France: 2006.
3. Bolla M, Collette L, Blank L, et al. Long term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer: a phase III randomized trial. Lancet. 2002;360:103–6.
4. Pilepich MV, Winter K, Lawton CA, et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long term results of phase III RTOG 85–31. Int J Radiat Oncol Biol Phys. 2005;61:1285–90.
5. Pilepich MV, Winter K, John MJ, et al. Phase III radiation therapy oncology group (RTOG) trial 86–10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2001;50:1243–52.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ¿Es el intervalo libre de docetaxel un factor predictivo para el cáncer de próstata resistente a la castración?;Actas Urológicas Españolas;2022-11
2. Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer?;Actas Urológicas Españolas (English Edition);2022-11
3. Risks of Serious Toxicities from Intermittent versus Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study;Journal of Urology;2017-05
4. 5α-Reductase Inhibition Coupled with Short Off Cycles Increases Survival in the LNCaP Xenograft Prostate Tumor Model on Intermittent Androgen Deprivation Therapy;Journal of Urology;2015-04
5. Degarelix: A Review of Its Use in Patients with Prostate Cancer;Drugs;2014-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3